STAT3 signaling in pulmonary arterial hypertension

References

• Archer S, Rich S. Primary pulmonary hypertension: a vascular biology and translational research “Work in progress”. Circulation 2000; 102:2781 - 91; http://dx.doi.org/10.1161/01.CIR.102.22.2781; PMID: 11094047
   PubMed Web of Science ®Google Scholar
• Ahmad S. Pulmonary hypertension and right heart failure. Chest 1995; 108:1773; http://dx.doi.org/10.1378/chest.108.6.1773; PMID: 7497812
   PubMed Web of Science ®Google Scholar
• Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 2010; 122:156 - 63; http://dx.doi.org/10.1161/CIRCULATIONAHA.109.911818; PMID: 20585011
   PubMed Web of Science ®Google Scholar
• Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation 2010; 122:164 - 72; http://dx.doi.org/10.1161/CIRCULATIONAHA.109.898122; PMID: 20585012
   PubMed Web of Science ®Google Scholar
• McMurtry MS, Archer SL, Altieri DC, Bonnet S, Haromy A, Harry G, et al. Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. J Clin Invest 2005; 115:1479 - 91; http://dx.doi.org/10.1172/JCI23203; PMID: 15931388
   PubMed Web of Science ®Google Scholar
• Voelkel NF, Cool C, Lee SD, Wright L, Geraci MW, Tuder RM. Primary pulmonary hypertension between inflammation and cancer. Chest 1998; 114:Suppl 225S - 30S; http://dx.doi.org/10.1378/chest.114.3_Supplement.225S; PMID: 9741573
   PubMedGoogle Scholar
• Paulin R, Courboulin A, Barrier M, Bonnet S. From oncoproteins/tumor suppressors to microRNAs, the newest therapeutic targets for pulmonary arterial hypertension. J Mol Med (Berl). 2011.
   Google Scholar
• Dorfmüller P, Perros F, Balabanian K, Humbert M. Inflammation in pulmonary arterial hypertension. Eur Respir J 2003; 22:358 - 63; http://dx.doi.org/10.1183/09031936.03.00038903; PMID: 12952274
   PubMed Web of Science ®Google Scholar
• Zhang S, Fantozzi I, Tigno DD, Yi ES, Platoshyn O, Thistlethwaite PA, et al. Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2003; 285:L740 - 54; PMID: 12740218
   PubMed Web of Science ®Google Scholar
• Nohe A, Hassel S, Ehrlich M, Neubauer F, Sebald W, Henis YI, et al. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J Biol Chem 2002; 277:5330 - 8; http://dx.doi.org/10.1074/jbc.M102750200; PMID: 11714695
   PubMed Web of Science ®Google Scholar
• Deng Z, Morse JH, Slager SL, Cuervo N, Moore KJ, Venetos G, et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 2000; 67:737 - 44; http://dx.doi.org/10.1086/303059; PMID: 10903931
   PubMed Web of Science ®Google Scholar
• Yang X, Long L, Southwood M, Rudarakanchana N, Upton PD, Jeffery TK, et al. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension. Circ Res 2005; 96:1053 - 63; http://dx.doi.org/10.1161/01.RES.0000166926.54293.68; PMID: 15845886
   PubMed Web of Science ®Google Scholar
• Moreno-Vinasco L, Gomberg-Maitland M, Maitland ML, Desai AA, Singleton PA, Sammani S, et al. Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertension. Physiol Genomics 2008; 33:278 - 91; http://dx.doi.org/10.1152/physiolgenomics.00169.2007; PMID: 18303084
   PubMed Web of Science ®Google Scholar
• Girerd B, Montani D, Coulet F, Sztrymf B, Yaici A, Jaïs X, et al. Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation. Am J Respir Crit Care Med 2010; 181:851 - 61; http://dx.doi.org/10.1164/rccm.200908-1284OC; PMID: 20056902
   PubMed Web of Science ®Google Scholar
• Eddahibi S, Chaouat A, Morrell N, Fadel E, Fuhrman C, Bugnet AS, et al. Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease. Circulation 2003; 108:1839 - 44; http://dx.doi.org/10.1161/01.CIR.0000091409.53101.E8; PMID: 14530202
   PubMed Web of Science ®Google Scholar
• Eddahibi S, Humbert M, Fadel E, Raffestin B, Darmon M, Capron F, et al. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest 2001; 108:1141 - 50; PMID: 11602621
   PubMed Web of Science ®Google Scholar
• Remillard CV, Tigno DD, Platoshyn O, Burg ED, Brevnova EE, Conger D, et al. Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension. Am J Physiol Cell Physiol 2007; 292:C1837 - 53; http://dx.doi.org/10.1152/ajpcell.00405.2006; PMID: 17267549
   PubMed Web of Science ®Google Scholar
• Lee SD, Shroyer KR, Markham NE, Cool CD, Voelkel NF, Tuder RM. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest 1998; 101:927 - 34; http://dx.doi.org/10.1172/JCI1910; PMID: 9486960
   PubMed Web of Science ®Google Scholar
• Mizuno S, Bogaard HJ, Kraskauskas D, Alhussaini A, Gomez-Arroyo J, Voelkel NF, et al. p53 gene deficiency promotes hypoxia-induced pulmonary hypertension and vascular remodeling in mice. Am J Physiol Lung Cell Mol Physiol 2011; 300:L753 - 61; http://dx.doi.org/10.1152/ajplung.00286.2010; PMID: 21335523
   PubMed Web of Science ®Google Scholar
• Chen SJ, Wang YB, Chen O, Zhu XB, Ma Y. [Effect of p21 gene transfection mediated by replication deficient adenovirus on the pulmonary hypertensive rat model]. Zhonghua Er Ke Za Zhi 2008; 46:139 - 42; PMID: 19099691
   PubMedGoogle Scholar
• Fouty BW, Grimison B, Fagan KA, Le Cras TD, Harral JW, Hoedt-Miller M, et al. p27(Kip1) is important in modulating pulmonary artery smooth muscle cell proliferation. Am J Respir Cell Mol Biol 2001; 25:652 - 8; PMID: 11713109
   PubMed Web of Science ®Google Scholar
• Yu L, Quinn DA, Garg HG, Hales CA. Cyclin-dependent kinase inhibitor p27Kip1, but not p21WAF1/Cip1, is required for inhibition of hypoxia-induced pulmonary hypertension and remodeling by heparin in mice. Circ Res 2005; 97:937 - 45; http://dx.doi.org/10.1161/01.RES.0000188211.83193.1a; PMID: 16195480
   PubMed Web of Science ®Google Scholar
• Ravi Y, Selvendiran K, Meduru S, Citro L, Naidu S, Khan M, et al. Dysregulation of PTEN in Cardiopulmonary Vascular Remodeling Induced by Pulmonary Hypertension. Cell Biochem Biophys 2011; In press http://dx.doi.org/10.1007/s12013-011-9332-z; PMID: 22205501
   PubMed Web of Science ®Google Scholar
• Koppenol WH, Bounds PL, Dang CV. Otto Warburg’s contributions to current concepts of cancer metabolism. Nat Rev Cancer 2011; 11:325 - 37; http://dx.doi.org/10.1038/nrc3038; PMID: 21508971
   PubMed Web of Science ®Google Scholar
• Sutendra G, Bonnet S, Rochefort G, Haromy A, Folmes KD, Lopaschuk GD, et al. Fatty acid oxidation and malonyl-CoA decarboxylase in the vascular remodeling of pulmonary hypertension. Sci Transl Med 2010; 2:44ra58; http://dx.doi.org/10.1126/scitranslmed.3001327; PMID: 20702857
   PubMed Web of Science ®Google Scholar
• Bonnet S, Rochefort G, Sutendra G, Archer SL, Haromy A, Webster L, et al. The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted. Proc Natl Acad Sci U S A 2007; 104:11418 - 23; http://dx.doi.org/10.1073/pnas.0610467104; PMID: 17596340
   PubMed Web of Science ®Google Scholar
• Sutendra G, Dromparis P, Wright P, Bonnet S, Haromy A, Hao Z, et al. The role of Nogo and the mitochondria-endoplasmic reticulum unit in pulmonary hypertension. Sci Transl Med 2011; 3:88ra55; http://dx.doi.org/10.1126/scitranslmed.3002194; PMID: 21697531
   PubMed Web of Science ®Google Scholar
• Paulin R, Courboulin A, Meloche J, Mainguy V, Dumas de la Roque E, Saksouk N, et al. Signal transducers and activators of transcription-3/pim1 axis plays a critical role in the pathogenesis of human pulmonary arterial hypertension. Circulation 2011; 123:1205 - 15; http://dx.doi.org/10.1161/CIRCULATIONAHA.110.963314; PMID: 21382889
   PubMed Web of Science ®Google Scholar
• Paulin R, Meloche J, Jacob MH, Bisserier M, Courboulin A, Bonnet S. Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol 2011; 301:H1798 - 809; http://dx.doi.org/10.1152/ajpheart.00654.2011; PMID: 21890685
   PubMed Web of Science ®Google Scholar
• Courboulin A, Paulin R, Giguère NJ, Saksouk N, Perreault T, Meloche J, et al. Role for miR-204 in human pulmonary arterial hypertension. J Exp Med 2011; 208:535 - 48; http://dx.doi.org/10.1084/jem.20101812; PMID: 21321078
   PubMed Web of Science ®Google Scholar
• Masri FA, Xu W, Comhair SA, Asosingh K, Koo M, Vasanji A, et al. Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 2007; 293:L548 - 54; http://dx.doi.org/10.1152/ajplung.00428.2006; PMID: 17526595
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646 - 74; http://dx.doi.org/10.1016/j.cell.2011.02.013; PMID: 21376230
   PubMed Web of Science ®Google Scholar
• Courboulin A, Tremblay VL, Barrier M, Meloche J, Jacob MH, Chapolard M, et al. Krüppel-like factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension. Respir Res 2011; 12:128; http://dx.doi.org/10.1186/1465-9921-12-128; PMID: 21951574
   PubMedGoogle Scholar
• Bonnet S, Archer SL, Allalunis-Turner J, Haromy A, Beaulieu C, Thompson R, et al. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 2007; 11:37 - 51; http://dx.doi.org/10.1016/j.ccr.2006.10.020; PMID: 17222789
   PubMed Web of Science ®Google Scholar
• Bromberg JF, Horvath CM, Besser D, Lathem WW, Darnell JE Jr.. Stat3 activation is required for cellular transformation by v-src. Mol Cell Biol 1998; 18:2553 - 8; PMID: 9566875
   PubMed Web of Science ®Google Scholar
• Darnell JE Jr.. STATs and gene regulation. Science 1997; 277:1630 - 5; http://dx.doi.org/10.1126/science.277.5332.1630; PMID: 9287210
   PubMed Web of Science ®Google Scholar
• Banes-Berceli AK, Ketsawatsomkron P, Ogbi S, Patel B, Pollock DM, Marrero MB. Angiotensin II and endothelin-1 augment the vascular complications of diabetes via JAK2 activation. Am J Physiol Heart Circ Physiol 2007; 293:H1291 - 9; http://dx.doi.org/10.1152/ajpheart.00181.2007; PMID: 17526654
   PubMedGoogle Scholar
• Csiszar A, Labinskyy N, Olson S, Pinto JT, Gupte S, Wu JM, et al. Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats. Hypertension 2009; 54:668 - 75; http://dx.doi.org/10.1161/HYPERTENSIONAHA.109.133397; PMID: 19597040
   PubMed Web of Science ®Google Scholar
• Schermuly RT, Dony E, Ghofrani HA, Pullamsetti S, Savai R, Roth M, et al. Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 2005; 115:2811 - 21; http://dx.doi.org/10.1172/JCI24838; PMID: 16200212
   PubMed Web of Science ®Google Scholar
• Frasch HF, Marshall C, Marshall BE. Endothelin-1 is elevated in monocrotaline pulmonary hypertension. Am J Physiol 1999; 276:L304 - 10; PMID: 9950893
   PubMed Web of Science ®Google Scholar
• Wen Z, Zhong Z, Darnell JE Jr.. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 1995; 82:241 - 50; http://dx.doi.org/10.1016/0092-8674(95)90311-9; PMID: 7543024
   PubMed Web of Science ®Google Scholar
• Banes AK, Shaw SM, Tawfik A, Patel BP, Ogbi S, Fulton D, et al. Activation of the JAK/STAT pathway in vascular smooth muscle by serotonin. Am J Physiol Cell Physiol 2005; 288:C805 - 12; http://dx.doi.org/10.1152/ajpcell.00385.2004; PMID: 15601754
   PubMedGoogle Scholar
• Potula HS, Wang D, Quyen DV, Singh NK, Kundumani-Sridharan V, Karpurapu M, et al. Src-dependent STAT-3-mediated expression of monocyte chemoattractant protein-1 is required for 15(S)-hydroxyeicosatetraenoic acid-induced vascular smooth muscle cell migration. J Biol Chem 2009; 284:31142 - 55; http://dx.doi.org/10.1074/jbc.M109.012526; PMID: 19736311
   PubMed Web of Science ®Google Scholar
• Wang GS, Qian GS, Mao BL, Cai WQ, Chen WZ, Chen Y. [Changes of interleukin-6 and Janus kinases in rats with hypoxic pulmonary hypertension]. Zhonghua Jie He He Hu Xi Za Zhi 2003; 26:664 - 7; PMID: 14703438
   PubMedGoogle Scholar
• Christmann RB, Hayes E, Pendergrass S, Padilla C, Farina G, Affandi AJ, et al. Interferon and alternative activation of monocyte/macrophages in systemic sclerosis-associated pulmonary arterial hypertension. Arthritis Rheum 2011; 63:1718 - 28; http://dx.doi.org/10.1002/art.30318; PMID: 21425123
   PubMed Web of Science ®Google Scholar
• Byers LA, Sen B, Saigal B, Diao L, Wang J, Nanjundan M, et al. Reciprocal regulation of c-Src and STAT3 in non-small cell lung cancer. Clin Cancer Res 2009; 15:6852 - 61; http://dx.doi.org/10.1158/1078-0432.CCR-09-0767; PMID: 19861436
   PubMed Web of Science ®Google Scholar
• Sen B, Peng S, Woods DM, Wistuba I, Bell D, El-Naggar AK, et al. STAT5A-mediated SOCS2 expression regulates Jak2 and STAT3 activity following c-Src inhibition in head and neck squamous carcinoma. Clin Cancer Res 2012; 18:127 - 39; http://dx.doi.org/10.1158/1078-0432.CCR-11-1889; PMID: 22090359
   PubMed Web of Science ®Google Scholar
• Singh NK, Wang D, Kundumani-Sridharan V, Van Quyen D, Niu J, Rao GN. 15-Lipoxygenase-1-enhanced Src-Janus kinase 2-signal transducer and activator of transcription 3 stimulation and monocyte chemoattractant protein-1 expression require redox-sensitive activation of epidermal growth factor receptor in vascular wall remodeling. J Biol Chem 2011; 286:22478 - 88; http://dx.doi.org/10.1074/jbc.M111.225060; PMID: 21536676
   PubMed Web of Science ®Google Scholar
• Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2000; 103:211 - 25; http://dx.doi.org/10.1016/S0092-8674(00)00114-8; PMID: 11057895
   PubMed Web of Science ®Google Scholar
• Hubbard SR. Juxtamembrane autoinhibition in receptor tyrosine kinases. Nat Rev Mol Cell Biol 2004; 5:464 - 71; http://dx.doi.org/10.1038/nrm1399; PMID: 15173825
   PubMed Web of Science ®Google Scholar
• Reddy EP, Korapati A, Chaturvedi P, Rane S. IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled. Oncogene 2000; 19:2532 - 47; http://dx.doi.org/10.1038/sj.onc.1203594; PMID: 10851052
   PubMed Web of Science ®Google Scholar
• Hofmeister R, Khaled AR, Benbernou N, Rajnavolgyi E, Muegge K, Durum SK. Interleukin-7: physiological roles and mechanisms of action. Cytokine Growth Factor Rev 1999; 10:41 - 60; http://dx.doi.org/10.1016/S1359-6101(98)00025-2; PMID: 10379911
   PubMed Web of Science ®Google Scholar
• Takahashi-Tezuka M, Hibi M, Fujitani Y, Fukada T, Yamaguchi T, Hirano T. Tec tyrosine kinase links the cytokine receptors to PI-3 kinase probably through JAK. Oncogene 1997; 14:2273 - 82; http://dx.doi.org/10.1038/sj.onc.1201071; PMID: 9178903
   PubMed Web of Science ®Google Scholar
• Xia K, Mukhopadhyay NK, Inhorn RC, Barber DL, Rose PE, Lee RS, et al. The cytokine-activated tyrosine kinase JAK2 activates Raf-1 in a p21ras-dependent manner. Proc Natl Acad Sci U S A 1996; 93:11681 - 6; http://dx.doi.org/10.1073/pnas.93.21.11681; PMID: 8876196
   PubMed Web of Science ®Google Scholar
• Yetter A, Uddin S, Krolewski JJ, Jiao H, Yi T, Platanias LC. Association of the interferon-dependent tyrosine kinase Tyk-2 with the hematopoietic cell phosphatase. J Biol Chem 1995; 270:18179 - 82; http://dx.doi.org/10.1074/jbc.270.31.18179; PMID: 7629131
   PubMed Web of Science ®Google Scholar
• Cabrera-Vera TM, Vanhauwe J, Thomas TO, Medkova M, Preininger A, Mazzoni MR, et al. Insights into G protein structure, function, and regulation. Endocr Rev 2003; 24:765 - 81; http://dx.doi.org/10.1210/er.2000-0026; PMID: 14671004
   PubMed Web of Science ®Google Scholar
• Milligan G, Stoddart LA, Brown AJ. G protein-coupled receptors for free fatty acids. Cell Signal 2006; 18:1360 - 5; http://dx.doi.org/10.1016/j.cellsig.2006.03.011; PMID: 16716567
   PubMed Web of Science ®Google Scholar
• Corre I, Baumann H, Hermouet S. Regulation by Gi2 proteins of v-fms-induced proliferation and transformation via Src-kinase and STAT3. Oncogene 1999; 18:6335 - 42; http://dx.doi.org/10.1038/sj.onc.1203010; PMID: 10597233
   PubMed Web of Science ®Google Scholar
• Ram PT, Horvath CM, Iyengar R. Stat3-mediated transformation of NIH-3T3 cells by the constitutively active Q205L Galphao protein. Science 2000; 287:142 - 4; http://dx.doi.org/10.1126/science.287.5450.142; PMID: 10615050
   PubMed Web of Science ®Google Scholar
• Liang H, Venema VJ, Wang X, Ju H, Venema RC, Marrero MB. Regulation of angiotensin II-induced phosphorylation of STAT3 in vascular smooth muscle cells. J Biol Chem 1999; 274:19846 - 51; http://dx.doi.org/10.1074/jbc.274.28.19846; PMID: 10391929
   PubMed Web of Science ®Google Scholar
• Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, Delafontaine P, et al. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 1995; 375:247 - 50; http://dx.doi.org/10.1038/375247a0; PMID: 7746328
   PubMed Web of Science ®Google Scholar
• Daub H, Weiss FU, Wallasch C, Ullrich A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 1996; 379:557 - 60; http://dx.doi.org/10.1038/379557a0; PMID: 8596637
   PubMed Web of Science ®Google Scholar
• Shah BH, Catt KJ. GPCR-mediated transactivation of RTKs in the CNS: mechanisms and consequences. Trends Neurosci 2004; 27:48 - 53; http://dx.doi.org/10.1016/j.tins.2003.11.003; PMID: 14698610
   PubMed Web of Science ®Google Scholar
• Wetzker R, Böhmer FD. Transactivation joins multiple tracks to the ERK/MAPK cascade. Nat Rev Mol Cell Biol 2003; 4:651 - 7; http://dx.doi.org/10.1038/nrm1173; PMID: 12923527
   PubMed Web of Science ®Google Scholar
• Akekawatchai C, Holland JD, Kochetkova M, Wallace JC, McColl SR. Transactivation of CXCR4 by the insulin-like growth factor-1 receptor (IGF-1R) in human MDA-MB-231 breast cancer epithelial cells. J Biol Chem 2005; 280:39701 - 8; http://dx.doi.org/10.1074/jbc.M509829200; PMID: 16172123
   PubMed Web of Science ®Google Scholar
• Delcourt N, Thouvenot E, Chanrion B, Galéotti N, Jouin P, Bockaert J, et al. PACAP type I receptor transactivation is essential for IGF-1 receptor signalling and antiapoptotic activity in neurons. EMBO J 2007; 26:1542 - 51; http://dx.doi.org/10.1038/sj.emboj.7601608; PMID: 17332755
   PubMed Web of Science ®Google Scholar
• Hobson JP, Rosenfeldt HM, Barak LS, Olivera A, Poulton S, Caron MG, et al. Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility. Science 2001; 291:1800 - 3; http://dx.doi.org/10.1126/science.1057559; PMID: 11230698
   PubMed Web of Science ®Google Scholar
• Mira E, Lacalle RA, González MA, Gómez-Moutón C, Abad JL, Bernad A, et al. A role for chemokine receptor transactivation in growth factor signaling. EMBO Rep 2001; 2:151 - 6; http://dx.doi.org/10.1093/embo-reports/kve027; PMID: 11258708
   PubMed Web of Science ®Google Scholar
• Pincheira R, Castro AF, Ozes ON, Idumalla PS, Donner DB. Type 1 TNF receptor forms a complex with and uses Jak2 and c-Src to selectively engage signaling pathways that regulate transcription factor activity. J Immunol 2008; 181:1288 - 98; PMID: 18606683
   PubMed Web of Science ®Google Scholar
• Meloche J, Paulin R, Courboulin A, Lambert C, Barrier M, Bonnet P, et al. RAGE-dependent activation of the oncoprotein Pim1 plays a critical role in systemic vascular remodeling processes. Arterioscler Thromb Vasc Biol 2011; 31:2114 - 24; http://dx.doi.org/10.1161/ATVBAHA.111.230573; PMID: 21680901
   PubMed Web of Science ®Google Scholar
• Lawrie A, Spiekerkoetter E, Martinez EC, Ambartsumian N, Sheward WJ, MacLean MR, et al. Interdependent serotonin transporter and receptor pathways regulate S100A4/Mts1, a gene associated with pulmonary vascular disease. Circ Res 2005; 97:227 - 35; http://dx.doi.org/10.1161/01.RES.0000176025.57706.1e; PMID: 16002749
   PubMed Web of Science ®Google Scholar
• Spiekerkoetter E, Guignabert C, de Jesus Perez V, Alastalo TP, Powers JM, Wang L, et al. S100A4 and bone morphogenetic protein-2 codependently induce vascular smooth muscle cell migration via phospho-extracellular signal-regulated kinase and chloride intracellular channel 4. Circ Res 2009; 105:639 - 47, 13, 647; http://dx.doi.org/10.1161/CIRCRESAHA.109.205120; PMID: 19713532
   PubMed Web of Science ®Google Scholar
• Sakaguchi T, Yan SF, Yan SD, Belov D, Rong LL, Sousa M, et al. Central role of RAGE-dependent neointimal expansion in arterial restenosis. J Clin Invest 2003; 111:959 - 72; PMID: 12671045
   PubMed Web of Science ®Google Scholar
• Kakisis JD, Pradhan S, Cordova A, Liapis CD, Sumpio BE. The role of STAT-3 in the mediation of smooth muscle cell response to cyclic strain. Int J Biochem Cell Biol 2005; 37:1396 - 406; http://dx.doi.org/10.1016/j.biocel.2005.01.009; PMID: 15833272
   PubMed Web of Science ®Google Scholar
• Padma R, Nagarajan L. The human PIM-1 gene product is a protein serine kinase. Cancer Res 1991; 51:2486 - 9; PMID: 1826633
   PubMed Web of Science ®Google Scholar
• Bonnet S, Paulin R, Sutendra G, Dromparis P, Roy M, Watson KO, et al. Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt/GSK3-beta/NFAT axis. Circulation 2009; 120:1231 - 40; http://dx.doi.org/10.1161/CIRCULATIONAHA.109.848911; PMID: 19752325
   PubMed Web of Science ®Google Scholar
• Chen X, Xu H, Yuan P, Fang F, Huss M, Vega VB, et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008; 133:1106 - 17; http://dx.doi.org/10.1016/j.cell.2008.04.043; PMID: 18555785
   PubMed Web of Science ®Google Scholar
• Li J, Piao YF, Jiang Z, Chen L, Sun HB. Silencing of signal transducer and activator of transcription 3 expression by RNA interference suppresses growth of human hepatocellular carcinoma in tumor-bearing nude mice. World J Gastroenterol 2009; 15:2602 - 8; http://dx.doi.org/10.3748/wjg.15.2602; PMID: 19496189
   PubMed Web of Science ®Google Scholar
• Glienke W, Maute L, Wicht J, Bergmann L. Curcumin inhibits constitutive STAT3 phosphorylation in human pancreatic cancer cell lines and downregulation of survivin/BIRC5 gene expression. Cancer Invest 2010; 28:166 - 71; http://dx.doi.org/10.3109/07357900903287006; PMID: 20121547
   PubMed Web of Science ®Google Scholar
• Yabkowitz R, Mansfield PJ, Ryan US, Suchard SJ. Thrombospondin mediates migration and potentiates platelet-derived growth factor-dependent migration of calf pulmonary artery smooth muscle cells. J Cell Physiol 1993; 157:24 - 32; http://dx.doi.org/10.1002/jcp.1041570104; PMID: 8408239
   PubMed Web of Science ®Google Scholar
• Yamboliev IA, Gerthoffer WT. Modulatory role of ERK MAPK-caldesmon pathway in PDGF-stimulated migration of cultured pulmonary artery SMCs. Am J Physiol Cell Physiol 2001; 280:C1680 - 8; PMID: 11350764
   PubMedGoogle Scholar
• Leung WC, Lawrie A, Demaries S, Massaeli H, Burry A, Yablonsky S, et al. Apolipoprotein D and platelet-derived growth factor-BB synergism mediates vascular smooth muscle cell migration. Circ Res 2004; 95:179 - 86; http://dx.doi.org/10.1161/01.RES.0000135482.74178.14; PMID: 15192024
   PubMed Web of Science ®Google Scholar
• Sarkar J, Gou D, Turaka P, Viktorova E, Ramchandran R, Raj JU. MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration. Am J Physiol Lung Cell Mol Physiol 2010; 299:L861 - 71; http://dx.doi.org/10.1152/ajplung.00201.2010; PMID: 20693317
   PubMedGoogle Scholar
• Negash S, Narasimhan SR, Zhou W, Liu J, Wei FL, Tian J, et al. Role of cGMP-dependent protein kinase in regulation of pulmonary vascular smooth muscle cell adhesion and migration: effect of hypoxia. Am J Physiol Heart Circ Physiol 2009; 297:H304 - 12; http://dx.doi.org/10.1152/ajpheart.00077.2008; PMID: 19411288
   PubMedGoogle Scholar
• Osada-Oka M, Ikeda T, Akiba S, Sato T. Hypoxia stimulates the autocrine regulation of migration of vascular smooth muscle cells via HIF-1alpha-dependent expression of thrombospondin-1. J Cell Biochem 2008; 104:1918 - 26; http://dx.doi.org/10.1002/jcb.21759; PMID: 18384112
   PubMed Web of Science ®Google Scholar
• Harvey KA, Welch Z, Sliva D, Siddiqui RA. Role of Rho kinase in sphingosine 1-phosphate-mediated endothelial and smooth muscle cell migration and differentiation. Mol Cell Biochem 2010; 342:7 - 19; http://dx.doi.org/10.1007/s11010-010-0461-2; PMID: 20401628
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay UK, Mooney P, Jia L, Eves R, Raptis L, Mak AS. Doubles game: Src-Stat3 versus p53-PTEN in cellular migration and invasion. Mol Cell Biol 2010; 30:4980 - 95; http://dx.doi.org/10.1128/MCB.00004-10; PMID: 20733006
   PubMed Web of Science ®Google Scholar
• Gao H, Priebe W, Glod J, Banerjee D. Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium. Stem Cells 2009; 27:857 - 65; http://dx.doi.org/10.1002/stem.23; PMID: 19350687
   PubMed Web of Science ®Google Scholar
• Li C, Wernig F, Leitges M, Hu Y, Xu Q. Mechanical stress-activated PKCdelta regulates smooth muscle cell migration. FASEB J 2003; 17:2106 - 8; PMID: 12958154
   PubMed Web of Science ®Google Scholar
• Shi Y, Wang C, Han S, Pang B, Zhang N, Wang J, et al. Determination of PKC isoform-specific protein expression in pulmonary arteries of rats with chronic hypoxia-induced pulmonary hypertension. Med Sci Monit 2012; 18:BR69 - 75; PMID: 22293869
   PubMedGoogle Scholar
• Kronfeld I, Kazimirsky G, Lorenzo PS, Garfield SH, Blumberg PM, Brodie C. Phosphorylation of protein kinase Cdelta on distinct tyrosine residues regulates specific cellular functions. J Biol Chem 2000; 275:35491 - 8; http://dx.doi.org/10.1074/jbc.M005991200; PMID: 10945993
   PubMed Web of Science ®Google Scholar
• Novotny-Diermayr V, Zhang T, Gu L, Cao X. Protein kinase C delta associates with the interleukin-6 receptor subunit glycoprotein (gp) 130 via Stat3 and enhances Stat3-gp130 interaction. J Biol Chem 2002; 277:49134 - 42; http://dx.doi.org/10.1074/jbc.M206727200; PMID: 12361954
   PubMed Web of Science ®Google Scholar
• Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995; 333:214 - 21; http://dx.doi.org/10.1056/NEJM199507273330403; PMID: 7540722
   PubMed Web of Science ®Google Scholar
• Sud N, Black SM. Endothelin-1 impairs nitric oxide signaling in endothelial cells through a protein kinase Cdelta-dependent activation of STAT3 and decreased endothelial nitric oxide synthase expression. DNA Cell Biol 2009; 28:543 - 53; http://dx.doi.org/10.1089/dna.2009.0865; PMID: 19754268
   PubMed Web of Science ®Google Scholar
• Kohanbash G, Okada H. MicroRNAs and STAT interplay. Semin Cancer Biol 2012; 22:70 - 5; http://dx.doi.org/10.1016/j.semcancer.2011.12.010; PMID: 22210182
   PubMed Web of Science ®Google Scholar
• Wu W, Lin Z, Zhuang Z, Liang X. Expression profile of mammalian microRNAs in endometrioid adenocarcinoma. Eur J Cancer Prev 2009; 18:50 - 5; http://dx.doi.org/10.1097/CEJ.0b013e328305a07a; PMID: 19077565
   PubMed Web of Science ®Google Scholar
• Wang FE, Zhang C, Maminishkis A, Dong L, Zhi C, Li R, et al. MicroRNA-204/211 alters epithelial physiology. FASEB J 2010; 24:1552 - 71; http://dx.doi.org/10.1096/fj.08-125856; PMID: 20056717
   PubMed Web of Science ®Google Scholar
• Senis YA, Tomlinson MG, Ellison S, Mazharian A, Lim J, Zhao Y, et al. The tyrosine phosphatase CD148 is an essential positive regulator of platelet activation and thrombosis. Blood 2009; 113:4942 - 54; http://dx.doi.org/10.1182/blood-2008-08-174318; PMID: 19246339
   PubMed Web of Science ®Google Scholar
• Wu JH, Goswami R, Cai X, Exum ST, Huang X, Zhang L, et al. Regulation of the platelet-derived growth factor receptor-beta by G protein-coupled receptor kinase-5 in vascular smooth muscle cells involves the phosphatase Shp2. J Biol Chem 2006; 281:37758 - 72; http://dx.doi.org/10.1074/jbc.M605756200; PMID: 17018529
   PubMed Web of Science ®Google Scholar
• Brock M, Trenkmann M, Gay RE, Michel BA, Gay S, Fischler M, et al. Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway. Circ Res 2009; 104:1184 - 91; http://dx.doi.org/10.1161/CIRCRESAHA.109.197491; PMID: 19390056
   PubMed Web of Science ®Google Scholar
• Rhee ST, Buchman SR. Colocalization of c-Src (pp60src) and bone morphogenetic protein 2/4 expression during mandibular distraction osteogenesis: in vivo evidence of their role within an integrin-mediated mechanotransduction pathway. Ann Plast Surg 2005; 55:207 - 15; http://dx.doi.org/10.1097/01.sap.0000164576.10754.aa; PMID: 16034255
   PubMed Web of Science ®Google Scholar
• Kopplow K, Wayss K, Enzmann H, Mayer D. Dehydroepiandrosterone causes hyperplasia and impairs regeneration in rat liver. Int J Oncol 2005; 27:1551 - 8; PMID: 16273211
   PubMed Web of Science ®Google Scholar
• Poczatková H, Bogdanová K, Uherková L, Cervenková K, Riegrová D, Rypka M, et al. Dehydroepiandrosterone effects on the mRNA levels of peroxisome proliferator-activated receptors and their coactivators in human hepatoma HepG2 cells. Gen Physiol Biophys 2007; 26:268 - 74; PMID: 18281744
   PubMed Web of Science ®Google Scholar
• Hansmann G, Wagner RA, Schellong S, Perez VA, Urashima T, Wang L, et al. Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation. Circulation 2007; 115:1275 - 84; PMID: 17339547
   PubMed Web of Science ®Google Scholar
• Ji JD, Kim HJ, Rho YH, Choi SJ, Lee YH, Cheon HJ, et al. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2. Rheumatology (Oxford) 2005; 44:983 - 8; http://dx.doi.org/10.1093/rheumatology/keh657; PMID: 15840591
   PubMed Web of Science ®Google Scholar
• Kim HJ, Rho YH, Choi SJ, Lee YH, Cheon H, Um JW, et al. 15-Deoxy-delta12,14-PGJ2 inhibits IL-6-induced Stat3 phosphorylation in lymphocytes. Exp Mol Med 2005; 37:179 - 85; PMID: 16000871
   PubMed Web of Science ®Google Scholar
• Wang LH, Yang XY, Zhang X, Huang J, Hou J, Li J, et al. Transcriptional inactivation of STAT3 by PPARgamma suppresses IL-6-responsive multiple myeloma cells. Immunity 2004; 20:205 - 18; http://dx.doi.org/10.1016/S1074-7613(04)00030-5; PMID: 14975242
   PubMed Web of Science ®Google Scholar
• Ehrmann J, Strakova N, Vrzalikova K, Hezova R, Kolar Z. Expression of STATs and their inhibitors SOCS and PIAS in brain tumors. In vitro and in vivo study. Neoplasma 2008; 55:482 - 7; PMID: 18999875
   PubMed Web of Science ®Google Scholar
• Juurlink DN, Gomes T, Lipscombe LL, Austin PC, Hux JE, Mamdani MM. Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study. BMJ 2009; 339:b2942; http://dx.doi.org/10.1136/bmj.b2942; PMID: 19690342
   PubMed Web of Science ®Google Scholar
• Abe K, Toba M, Alzoubi A, Ito M, Fagan KA, Cool CD, et al. Formation of plexiform lesions in experimental severe pulmonary arterial hypertension. Circulation 2010; 121:2747 - 54; http://dx.doi.org/10.1161/CIRCULATIONAHA.109.927681; PMID: 20547927
   PubMed Web of Science ®Google Scholar
• Courboulin A, Barrier M, Perreault T, Bonnet P, Tremblay VL, Paulin R, et al. Plumbagin reverses proliferation and resistance to apoptosis in experimental PAH. Eur Respir J 2012; 40:618 - 29; http://dx.doi.org/10.1183/09031936.00084211; PMID: 22496325
   PubMed Web of Science ®Google Scholar
• Mauritz GJ, Kind T, Marcus JT, Bogaard HJ, van de Veerdonk M, Postmus PE, et al. Progressive changes in right ventricular geometric shortening and long-term survival in pulmonary arterial hypertension. Chest 2012; 141:935 - 43; http://dx.doi.org/10.1378/chest.10-3277; PMID: 21960697
   PubMed Web of Science ®Google Scholar
• Kunisada K, Negoro S, Tone E, Funamoto M, Osugi T, Yamada S, et al. Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. Proc Natl Acad Sci U S A 2000; 97:315 - 9; http://dx.doi.org/10.1073/pnas.97.1.315; PMID: 10618415
   PubMed Web of Science ®Google Scholar
• Negoro S, Kunisada K, Fujio Y, Funamoto M, Darville MI, Eizirik DL, et al. Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase. Circulation 2001; 104:979 - 81; http://dx.doi.org/10.1161/hc3401.095947; PMID: 11524388
   PubMed Web of Science ®Google Scholar
• Stephanou A, Latchman DS. Transcriptional regulation of the heat shock protein genes by STAT family transcription factors. Gene Expr 1999; 7:311 - 9; PMID: 10440232
   PubMed Web of Science ®Google Scholar
• Yamauchi-Takihara K, Kishimoto T. A novel role for STAT3 in cardiac remodeling. Trends Cardiovasc Med 2000; 10:298 - 303; http://dx.doi.org/10.1016/S1050-1738(01)00066-4; PMID: 11343970
   PubMed Web of Science ®Google Scholar
• Hilfiker-Kleiner D, Hilfiker A, Fuchs M, Kaminski K, Schaefer A, Schieffer B, et al. Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ Res 2004; 95:187 - 95; http://dx.doi.org/10.1161/01.RES.0000134921.50377.61; PMID: 15192020
   PubMed Web of Science ®Google Scholar
• Lu Y, Zhou J, Xu C, Lin H, Xiao J, Wang Z, et al. JAK/STAT and PI3K/AKT pathways form a mutual transactivation loop and afford resistance to oxidative stress-induced apoptosis in cardiomyocytes. Cell Physiol Biochem 2008; 21:305 - 14; http://dx.doi.org/10.1159/000129389; PMID: 18441519
   PubMed Web of Science ®Google Scholar
• Haas M, Askari A, Xie Z. Involvement of Src and epidermal growth factor receptor in the signal-transducing function of Na+/K+-ATPase. J Biol Chem 2000; 275:27832 - 7; PMID: 10874030
   PubMed Web of Science ®Google Scholar
• Takeishi Y, Huang Q, Abe J, Glassman M, Che W, Lee JD, et al. Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: comparison with acute mechanical stretch. J Mol Cell Cardiol 2001; 33:1637 - 48; http://dx.doi.org/10.1006/jmcc.2001.1427; PMID: 11549343
   PubMed Web of Science ®Google Scholar
• Willey CD, Palanisamy AP, Johnston RK, Mani SK, Shiraishi H, Tuxworth WJ, et al. STAT3 activation in pressure-overloaded feline myocardium: role for integrins and the tyrosine kinase BMX. Int J Biol Sci 2008; 4:184 - 99; http://dx.doi.org/10.7150/ijbs.4.184; PMID: 18612371
   PubMed Web of Science ®Google Scholar
• Huang J, Kaminski PM, Edwards JG, Yeh A, Wolin MS, Frishman WH, et al. Pyrrolidine dithiocarbamate restores endothelial cell membrane integrity and attenuates monocrotaline-induced pulmonary artery hypertension. Am J Physiol Lung Cell Mol Physiol 2008; 294:L1250 - 9; http://dx.doi.org/10.1152/ajplung.00069.2007; PMID: 18390833
   PubMed Web of Science ®Google Scholar
• Huang J, Wolk JH, Gewitz MH, Mathew R. Progressive endothelial cell damage in an inflammatory model of pulmonary hypertension. Exp Lung Res 2010; 36:57 - 66; http://dx.doi.org/10.3109/01902140903104793; PMID: 20128682
   PubMed Web of Science ®Google Scholar
• Greenway S, van Suylen RJ, Du Marchie Sarvaas G, Kwan E, Ambartsumian N, Lukanidin E, et al. S100A4/Mts1 produces murine pulmonary artery changes resembling plexogenic arteriopathy and is increased in human plexogenic arteriopathy. Am J Pathol 2004; 164:253 - 62; http://dx.doi.org/10.1016/S0002-9440(10)63115-X; PMID: 14695338
   PubMed Web of Science ®Google Scholar
• Katsha AM, Ohkouchi S, Xin H, Kanehira M, Sun R, Nukiwa T, et al. Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model. Mol Ther 2011; 19:196 - 203; http://dx.doi.org/10.1038/mt.2010.192; PMID: 20842104
   PubMed Web of Science ®Google Scholar
• Tuder RM, Groves B, Badesch DB, Voelkel NF. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 1994; 144:275 - 85; PMID: 7508683
   PubMed Web of Science ®Google Scholar
• Ulrich S, Taraseviciene-Stewart L, Huber LC, Speich R, Voelkel N. Peripheral blood B lymphocytes derived from patients with idiopathic pulmonary arterial hypertension express a different RNA pattern compared with healthy controls: a cross sectional study. Respir Res 2008; 9:20; http://dx.doi.org/10.1186/1465-9921-9-20; PMID: 18269757
   PubMed Web of Science ®Google Scholar
• Ulrich S, Nicolls MR, Taraseviciene L, Speich R, Voelkel N. Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension. Respiration 2008; 75:272 - 80; http://dx.doi.org/10.1159/000111548; PMID: 18025812
   PubMed Web of Science ®Google Scholar
• Perros F, Dorfmüller P, Souza R, Durand-Gasselin I, Mussot S, Mazmanian M, et al. Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension. Eur Respir J 2007; 29:462 - 8; http://dx.doi.org/10.1183/09031936.00094706; PMID: 17107989
   PubMed Web of Science ®Google Scholar
• Gabrilovich D. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat Rev Immunol 2004; 4:941 - 52; http://dx.doi.org/10.1038/nri1498; PMID: 15573129
   PubMed Web of Science ®Google Scholar
• Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, Nadaf S, et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 1996; 2:1096 - 103; http://dx.doi.org/10.1038/nm1096-1096; PMID: 8837607
   PubMed Web of Science ®Google Scholar
• Ohm JE, Gabrilovich DI, Sempowski GD, Kisseleva E, Parman KS, Nadaf S, et al. VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression. Blood 2003; 101:4878 - 86; http://dx.doi.org/10.1182/blood-2002-07-1956; PMID: 12586633
   PubMed Web of Science ®Google Scholar
• Visinoni F. [Milestone bring forth new idea on pathological laboratory]. Zhonghua Bing Li Xue Za Zhi 2004; 33:283 - 4; PMID: 15256132
   PubMedGoogle Scholar
• Lee H, Pal SK, Reckamp K, Figlin RA, Yu H. STAT3: a target to enhance antitumor immune response. Curr Top Microbiol Immunol 2011; 344:41 - 59; http://dx.doi.org/10.1007/82_2010_51; PMID: 20517723
   PubMed Web of Science ®Google Scholar
• Macian F. NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 2005; 5:472 - 84; http://dx.doi.org/10.1038/nri1632; PMID: 15928679
   PubMed Web of Science ®Google Scholar
• Wegrzyn J, Potla R, Chwae YJ, Sepuri NB, Zhang Q, Koeck T, et al. Function of mitochondrial Stat3 in cellular respiration. Science 2009; 323:793 - 7; http://dx.doi.org/10.1126/science.1164551; PMID: 19131594
   PubMed Web of Science ®Google Scholar
• Huang G, Lu H, Hao A, Ng DC, Ponniah S, Guo K, et al. GRIM-19, a cell death regulatory protein, is essential for assembly and function of mitochondrial complex I. Mol Cell Biol 2004; 24:8447 - 56; http://dx.doi.org/10.1128/MCB.24.19.8447-8456.2004; PMID: 15367666
   PubMed Web of Science ®Google Scholar
• Lu H, Cao X. GRIM-19 is essential for maintenance of mitochondrial membrane potential. Mol Biol Cell 2008; 19:1893 - 902; http://dx.doi.org/10.1091/mbc.E07-07-0683; PMID: 18287540
   PubMed Web of Science ®Google Scholar
• Lufei C, Ma J, Huang G, Zhang T, Novotny-Diermayr V, Ong CT, et al. GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction. EMBO J 2003; 22:1325 - 35; http://dx.doi.org/10.1093/emboj/cdg135; PMID: 12628925
   PubMed Web of Science ®Google Scholar
• Zhang J, Yang J, Roy SK, Tininini S, Hu J, Bromberg JF, et al. The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3. Proc Natl Acad Sci U S A 2003; 100:9342 - 7; http://dx.doi.org/10.1073/pnas.1633516100; PMID: 12867595
   PubMed Web of Science ®Google Scholar
• Demaria M, Misale S, Giorgi C, Miano V, Camporeale A, Campisi J, et al. STAT3 can serve as a hit in the process of malignant transformation of primary cells. Cell Death Differ 2012; 19:1390 - 7; http://dx.doi.org/10.1038/cdd.2012.20; PMID: 22402588
   PubMed Web of Science ®Google Scholar
• Niu G, Briggs J, Deng J, Ma Y, Lee H, Kortylewski M, et al. Signal transducer and activator of transcription 3 is required for hypoxia-inducible factor-1alpha RNA expression in both tumor cells and tumor-associated myeloid cells. Mol Cancer Res 2008; 6:1099 - 105; http://dx.doi.org/10.1158/1541-7786.MCR-07-2177; PMID: 18644974
   PubMed Web of Science ®Google Scholar
• Hagihara K, Nishikawa T, Sugamata Y, Song J, Isobe T, Taga T, et al. Essential role of STAT3 in cytokine-driven NF-kappaB-mediated serum amyloid A gene expression. Genes Cells 2005; 10:1051 - 63; http://dx.doi.org/10.1111/j.1365-2443.2005.00900.x; PMID: 16236134
   PubMed Web of Science ®Google Scholar
• Yu Z, Zhang W, Kone BC. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB. Biochem J 2002; 367:97 - 105; http://dx.doi.org/10.1042/BJ20020588; PMID: 12057007
   PubMed Web of Science ®Google Scholar
• Yoshida Y, Kumar A, Koyama Y, Peng H, Arman A, Boch JA, et al. Interleukin 1 activates STAT3/nuclear factor-kappaB cross-talk via a unique TRAF6- and p65-dependent mechanism. J Biol Chem 2004; 279:1768 - 76; http://dx.doi.org/10.1074/jbc.M311498200; PMID: 14593105
   PubMed Web of Science ®Google Scholar
• Yang J, Chatterjee-Kishore M, Staugaitis SM, Nguyen H, Schlessinger K, Levy DE, et al. Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation. Cancer Res 2005; 65:939 - 47; PMID: 15705894
   PubMed Web of Science ®Google Scholar
• Yang J, Liao X, Agarwal MK, Barnes L, Auron PE, Stark GR. Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. Genes Dev 2007; 21:1396 - 408; http://dx.doi.org/10.1101/gad.1553707; PMID: 17510282
   PubMed Web of Science ®Google Scholar
• Lee H, Herrmann A, Deng JH, Kujawski M, Niu G, Li Z, et al. Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors. Cancer Cell 2009; 15:283 - 93; http://dx.doi.org/10.1016/j.ccr.2009.02.015; PMID: 19345327
   PubMed Web of Science ®Google Scholar
• Sehgal PB, Mukhopadhyay S, Patel K, Xu F, Almodóvar S, Tuder RM, et al. Golgi dysfunction is a common feature in idiopathic human pulmonary hypertension and vascular lesions in SHIV-nef-infected macaques. Am J Physiol Lung Cell Mol Physiol 2009; 297:L729 - 37; http://dx.doi.org/10.1152/ajplung.00087.2009; PMID: 19648286
   PubMed Web of Science ®Google Scholar
• Voeltz GK, Prinz WA, Shibata Y, Rist JM, Rapoport TA. A class of membrane proteins shaping the tubular endoplasmic reticulum. Cell 2006; 124:573 - 86; http://dx.doi.org/10.1016/j.cell.2005.11.047; PMID: 16469703
   PubMed Web of Science ®Google Scholar
• Li W, Dunmore BJ, Morrell NW. Bone morphogenetic protein type II receptor mutations causing protein misfolding in heritable pulmonary arterial hypertension. Proc Am Thorac Soc 2010; 7:395 - 8; http://dx.doi.org/10.1513/pats.201002-024AW; PMID: 21030519
   PubMedGoogle Scholar
• Lee JE, Yang YM, Liang FX, Gough DJ, Levy DE, Sehgal PB. Nongenomic STAT5-dependent effects on Golgi apparatus and endoplasmic reticulum structure and function. Am J Physiol Cell Physiol 2012; 302:C804 - 20; http://dx.doi.org/10.1152/ajpcell.00379.2011; PMID: 22159083
   PubMedGoogle Scholar